RxDoctor Payments Data

Ki Hon Lin, MD

Orthopaedic Surgery of the Spine · Carrollton, GANPI 1851394837

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $119,380 of the $166,199 with a category attached, or 71.8%. Royal Biologics, Inc. accounts for 83.0% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $42,106, 7.1 times the $5,952 reported in 2019.

$166,199in general payments, 2019–2025

Across 362 payments — averaging $459.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Royal Biologics, Inc.$138K
  • 4web, Inc.$20K
  • Stryker$3K
  • Globus Medical$2K
  • Medtronic$2K
  • VB Spine LLC$167
  • plus $760 from 15 others

What the payments were for

  • Royalty or licence$119,38072%
  • Consulting fees$24,02814%
  • Speaking & faculty fees$5000%
  • Travel & lodging$8,1735%
  • Food & beverage$13,9818%
  • Education$1370%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$166,199 in reported general payments places this provider in the 70th percentile of 57 orthopaedic surgery of the spine providers in Georgia.

See all orthopaedic surgery of the spine providers in Georgia

Medicare billing

Part B allowed, 2024
$177,096
Medicare patients
400
Services billed
9,497

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin539$4,809
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen477$3,081
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen370$2,880
Fentanyl13$2,592
Tramadol Hcl671$2,149
Diclofenac Sodium73$1,170
Pregabalin59$656
Celecoxib39$641
Prednisone389$565
Cyclobenzaprine Hcl92$512
Tizanidine Hcl68$510
Ondansetron OdtOndansetron18$472
Methocarbamol70$375
Baclofen43$358
Meloxicam133$342

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Carrollton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →